Retraction: Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by Norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
Saved in:
| Main Author: | PLOS One Editors |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0319593 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Platelet rich plasma promotes cell migration of adipose-derived stem cells by up-regulation of focal adhesion kinase and paxillin
by: Karis Chen, et al.
Published: (2025-12-01) -
Microbial Metabolite Effects on Vasculogenic Mimicry in Metastatic Cancers
by: Mohammad Kamalabadi Farahani, et al.
Published: (2025-05-01) -
LncRNAs Regulate Vasculogenic Mimicry in Human Cancers
by: Eloísa Ibarra-Sierra, et al.
Published: (2025-04-01) -
Machine learning identification of a novel vasculogenic mimicry-related signature and FOXM1’s role in promoting vasculogenic mimicry in clear cell renal cell carcinoma
by: Chao Xu, et al.
Published: (2025-03-01) -
A novel vasculogenic mimicry-related nomogram predicts prognosis in hepatocellular carcinoma
by: Yun Zhong, et al.
Published: (2025-07-01)